Johnston et al. demonstrated that specific EV subgroups can effectively predict neurocognitive disorders in older HIV-infected individuals, with increased levels of CCR5+ EVs positively correlating with cognitive impairment (128). Here, CCR5 is linked to Cognitive impairment.